AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 12450951 — intervention group
Group type: COMPARATOR
Intervention: Stable-poor premorbid functioning group
Number of subjects: 535
Study 12450951 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive measures
Number of subjects: 535
Study 12450951 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive syndrome subscale of the Positive and Negative Syndrome Scale
Number of subjects: 535
Study 11515806 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical spinal manipulation
Number of subjects: 0
Study 11515806 — intervention group
Group type: COMPARATOR
Intervention: Sham procedure
Number of subjects: 0
Study 9140153 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole (80 mg as bolus, followed by 8 mg/h for 72 hours, plus 20 mg orally from day 3 until follow-up on day 21)
Number of subjects: 274
Study 9140153 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 274
Study 8430920 — intervention group
Group type: EXPERIMENTAL
Intervention: Cetirizine 40 mg
Number of subjects: 178
Study 8430920 — intervention group
Group type: EXPERIMENTAL
Intervention: Cetirizine 20 mg
Number of subjects: 178
Study 8430920 — intervention group
Group type: EXPERIMENTAL
Intervention: Cetirizine 10 mg
Number of subjects: 178
Study 8430920 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 178
Study 3327892 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicergoline
Number of subjects: 60
Study 3327892 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 29268153 — intervention group
Group type: EXPERIMENTAL
Intervention: Symptoms of depression assessed using the Patient Health Questionnaire (PHQ)
Number of subjects: 11246
Study 29268153 — intervention group
Group type: EXPERIMENTAL
Intervention: Symptoms of generalized anxiety assessed using the Patient Health Questionnaire (PHQ)
Number of subjects: 11246
Study 29268153 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined symptoms of depression and generalized anxiety
Number of subjects: 11246
Study 29268153 — intervention group
Group type: EXPERIMENTAL
Intervention: Co-morbidity with symptoms of generalized anxiety
Number of subjects: 11246
Study 29268153 — intervention group
Group type: EXPERIMENTAL
Intervention: Co-morbidity with somatic symptoms, alcohol use problems, and disability
Number of subjects: 11246
Study 29268153 — intervention group
Group type: EXPERIMENTAL
Intervention: Sociodemographic factors associated with symptoms of depression or generalized anxiety
Number of subjects: 11246
Study 28923118 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-body cooling with usual care
Number of subjects: 408
Study 28923118 — intervention group
Group type: COMPARATOR
Intervention: Usual care alone
Number of subjects: 408
Study 24589123 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Control Training (CCT)
Number of subjects: 48
Study 24589123 — intervention group
Group type: COMPARATOR
Intervention: Peripheral Vision Training (PVT)
Number of subjects: 48
Study 23288914 — intervention group
Group type: EXPERIMENTAL
Intervention: Levosimendan
Number of subjects: 61
Study 23288914 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61
Study 21891871 — intervention group
Group type: EXPERIMENTAL
Intervention: Galantamine treatment
Number of subjects: 258
Study 21891871 — intervention group
Group type: EXPERIMENTAL
Intervention: Discontinued galantamine treatment
Number of subjects: 258
Study 21891871 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group from previous trials)
Number of subjects: 258
Study 17932613 — intervention group
Group type: EXPERIMENTAL
Intervention: Active treatment (trans-sacral magnetic stimulation)
Number of subjects: 63
Study 17932613 — intervention group
Group type: COMPARATOR
Intervention: Placebo (sham device)
Number of subjects: 63
Study 16626573 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracoronary injection of autologous mesenchymal stem cells (n = 12)
Number of subjects: 24
Study 16626573 — intervention group
Group type: COMPARATOR
Intervention: Saline (control, n = 12)
Number of subjects: 24
Study 15107912 — intervention group
Group type: EXPERIMENTAL
Intervention: Paradontax dentifrice
Number of subjects: 30
Study 15107912 — intervention group
Group type: COMPARATOR
Intervention: Standard dentifrice with fluoride (Control)
Number of subjects: 30
Study 10618026 — intervention group
Group type: EXPERIMENTAL
Intervention: Paroxetine
Number of subjects: 27
Study 10618026 — intervention group
Group type: COMPARATOR
Intervention: Second mood stabilizer (lithium carbonate or divalproex sodium)
Number of subjects: 27
Study 9169961 — intervention group
Group type: EXPERIMENTAL
Intervention: Clomipramine
Number of subjects: 39
Study 9169961 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluvoxamine
Number of subjects: 39
Study 9169961 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study 8247887 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental approach to preparation for surgery; details on dosage and duration not available.
Number of subjects: 0
Study 31461220 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermediate endpoint associated with survival in a randomized phase 2 trial
Number of subjects: 0
Study 31461220 — intervention group
Group type: EXPERIMENTAL
Intervention: Futility interim analysis
Number of subjects: 0
Study 31461220 — intervention group
Group type: EXPERIMENTAL
Intervention: Cure proportion model
Number of subjects: 0
Study 31461220 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomized phase 2 trial
Number of subjects: 0
Study 30129666 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrocortisone 200 mg
Number of subjects: 10
Study 30129666 — intervention group
Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 10
Study 27510630 — intervention group
Group type: EXPERIMENTAL
Intervention: T1w‐3D black‐blood turbo spin echo (TSE) sequence with variable flip angles
Number of subjects: 70
Study 27510630 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified intervention)
Number of subjects: 70
Study 25786056 — intervention group
Group type: EXPERIMENTAL
Intervention: Twin-block appliance (TB)
Number of subjects: 28
Study 25786056 — intervention group
Group type: EXPERIMENTAL
Intervention: Forsus Fatigue Resistant Device (FRD)
Number of subjects: 28
Study 25786056 — intervention group
Group type: COMPARATOR
Intervention: Control group (untreated Class II malocclusion)
Number of subjects: 28
Study 23527347 — intervention group
Group type: EXPERIMENTAL
Intervention: Silicone prostheses
Number of subjects: 42
Study 23527347 — intervention group
Group type: COMPARATOR
Intervention: CPE prostheses
Number of subjects: 42
Study 21051130 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile AED Map
Number of subjects: 43
Study 21051130 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 43
Study 18374840 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin glargine (once daily)
Number of subjects: 418
Study 18374840 — intervention group
Group type: COMPARATOR
Intervention: Insulin lispro (thrice daily)
Number of subjects: 418
Study 17017665 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous itraconazole
Number of subjects: 96
Study 17017665 — intervention group
Group type: COMPARATOR
Intervention: Amphotericin B deoxycholate
Number of subjects: 96
Study 17017665 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 96
Study 14571829 — intervention group
Group type: EXPERIMENTAL
Intervention: OCM-O group (omeprazole 20 mg once daily)
Number of subjects: 79
Study 14571829 — intervention group
Group type: COMPARATOR
Intervention: OCM group (without acid suppressing agents)
Number of subjects: 79
Study 10774106 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical nerve stimulation (TENS)
Number of subjects: 50
Study 10774106 — intervention group
Group type: COMPARATOR
Intervention: Intravenous administration of 1 g of Dipyrone
Number of subjects: 50
Study 8918414 — intervention group
Group type: COMPARATOR
Intervention: Placebo antiemetic
Number of subjects: 48
Study 8918414 — intervention group
Group type: EXPERIMENTAL
Intervention: Granisetron, Metoclopramide, Ondansetron
Number of subjects: 48
Study 1432803 — intervention group
Group type: EXPERIMENTAL
Intervention: Cingulum bar (test) removable partial denture framework
Number of subjects: 0
Study 1432803 — intervention group
Group type: COMPARATOR
Intervention: Linguoplate (control) removable partial denture framework
Number of subjects: 0
Study 2866338 — intervention group
Group type: EXPERIMENTAL
Intervention: Stilboestrol 5 mg daily
Number of subjects: 11
Study 2866338 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study 29628406 — intervention group
Group type: EXPERIMENTAL
Intervention: Eccentric training (ECC)
Number of subjects: 43
Study 29628406 — intervention group
Group type: EXPERIMENTAL
Intervention: Eccentric training combined to NMES (ECC+NMES)
Number of subjects: 43
Study 29628406 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 43
Study 27182761 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Shuttle Test (MST)
Number of subjects: 20
Study 27182761 — intervention group
Group type: COMPARATOR
Intervention: Cardiopulmonary Exercise Test (CPET)
Number of subjects: 20
Study 24534170 — intervention group
Group type: EXPERIMENTAL
Intervention: gelled pectin (10 g)
Number of subjects: 29
Study 24534170 — intervention group
Group type: EXPERIMENTAL
Intervention: viscous pectin (10 g)
Number of subjects: 29
Study 24534170 — intervention group
Group type: EXPERIMENTAL
Intervention: gelled test product
Number of subjects: 29
Study 24534170 — intervention group
Group type: EXPERIMENTAL
Intervention: capsules
Number of subjects: 29
Study 22417085 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduced individualized GH dose (RID, n=28)
Number of subjects: 98
Study 22417085 — intervention group
Group type: COMPARATOR
Intervention: Unchanged individualized GH dose (UID, n=37)
Number of subjects: 98
Study 22417085 — intervention group
Group type: COMPARATOR
Intervention: Standard GH dose (FIX, n=33)
Number of subjects: 98
Study 19685066 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcervical amnioinfusion
Number of subjects: 292
Study 19685066 — intervention group
Group type: COMPARATOR
Intervention: Control (no amnioinfusion)
Number of subjects: 292
Study 16394962 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral feedback intervention
Number of subjects: 79
Study 16394962 — intervention group
Group type: COMPARATOR
Intervention: Information-only condition
Number of subjects: 79
Study 15315244 — intervention group
Group type: EXPERIMENTAL
Intervention: Optimal seated positioning in individually fitted furniture
Number of subjects: 40
Study 15315244 — intervention group
Group type: COMPARATOR
Intervention: Suboptimal seated positioning in standard classroom furniture
Number of subjects: 40
Study 11513785 — intervention group
Group type: EXPERIMENTAL
Intervention: Strategic Management Simulation (SMS)
Number of subjects: 0
Study 11513785 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulation performance measures (activity level, response speed, initiative, adequate usage of and appropriate search for relevant information)
Number of subjects: 0
Study 11513785 — intervention group
Group type: COMPARATOR
Intervention: Faculty ratings
Number of subjects: 0
Study 9266623 — intervention group
Group type: EXPERIMENTAL
Intervention: r‐HuEPO (300 U/kg body weight)
Number of subjects: 46
Study 9266623 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study 9266623 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy (oral iron + r‐HuEPO)
Number of subjects: 46
Study 9266623 — intervention group
Group type: COMPARATOR
Intervention: r‐HuEPO alone
Number of subjects: 46
Study 8278067 — intervention group
Group type: EXPERIMENTAL
Intervention: Meclofenamic acid 100 mg
Number of subjects: 60
Study 8278067 — intervention group
Group type: COMPARATOR
Intervention: Ketoprofene 50 mg
Number of subjects: 60
Study 2874415 — intervention group
Group type: EXPERIMENTAL
Intervention: levodopa
Number of subjects: 20
Study 2874415 — intervention group
Group type: COMPARATOR
Intervention: lactose
Number of subjects: 20
Study 30601709 — intervention group
Group type: EXPERIMENTAL
Intervention: CJR program (bundled payments)
Number of subjects: 803
Study 27845950 — intervention group
Group type: EXPERIMENTAL
Intervention: CO2 insufflation
Number of subjects: 64
Study 27845950 — intervention group
Group type: COMPARATOR
Intervention: Air insufflation
Number of subjects: 64
Study 26654962 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 0
Study 26654962 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 24126369 — intervention group
Group type: EXPERIMENTAL
Intervention: Transarterial ethanol ablation (TEA)
Number of subjects: 200
Study 24126369 — intervention group
Group type: COMPARATOR
Intervention: Transcatheter arterial chemoembolization (TACE)
Number of subjects: 200
Study 23029408 — intervention group
Group type: EXPERIMENTAL
Intervention: 7vPnC followed by PPV
Number of subjects: 80
Study 23029408 — intervention group
Group type: COMPARATOR
Intervention: PPV
Number of subjects: 80
Study 19031485 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative peer evaluation outcome
Number of subjects: 142
Study 19031485 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive peer evaluation outcome
Number of subjects: 142
Study 19031485 — intervention group
Group type: EXPERIMENTAL
Intervention: Neutral peer evaluation outcome
Number of subjects: 142
Study 17762286 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous Conditioned Serum (ACS)
Number of subjects: 84
Study 17762286 — intervention group
Group type: COMPARATOR
Intervention: 5 mg triamcinolone
Number of subjects: 84
Study 17762286 — intervention group
Group type: COMPARATOR
Intervention: 10 mg triamcinolone
Number of subjects: 84
Study 15747895 — intervention group
Group type: EXPERIMENTAL
Intervention: Occupational therapy intervention (EG-IA) - tooth brushing taught and monitored by an occupational therapist
Number of subjects: 61
Study 15747895 — intervention group
Group type: COMPARATOR
Intervention: Placebo activity (CG-IA) - weekly manicure by the same person
Number of subjects: 61
Study 15747895 — intervention group
Group type: EXPERIMENTAL
Intervention: Occupational therapy intervention (EG)
Number of subjects: 61
Study 15747895 — intervention group
Group type: COMPARATOR
Intervention: Placebo activity (CG)
Number of subjects: 61
Study 11865274 — intervention group
Group type: EXPERIMENTAL
Intervention: Soy formula
Number of subjects: 170
Study 11865274 — intervention group
Group type: COMPARATOR
Intervention: Extensively hydrolyzed formula
Number of subjects: 170
Study 10461254 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunotherapy (IT)
Number of subjects: 19
Study 10461254 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 19
Study 8786245 — intervention group
Group type: EXPERIMENTAL
Intervention: rHu GM‐CSF
Number of subjects: 16
Study 8786245 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 2079571 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon alfa-2b 3 million units thrice weekly for 14-16 weeks
Number of subjects: 50
Study 2079571 — intervention group
Group type: COMPARATOR
Intervention: Control (untreated)
Number of subjects: 50
Study 2079571 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon alfa-2b therapy
Number of subjects: 50
Study 37874 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-blockers
Number of subjects: 0
Study 37874 — intervention group
Group type: EXPERIMENTAL
Intervention: Diuretics
Number of subjects: 0
Study 37874 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of beta-blockers and diuretics
Number of subjects: 0
Study 31082269 — intervention group
Group type: EXPERIMENTAL
Intervention: NAB-paclitaxel 150 mg/m2 (after study amendment, 125 mg/m2)
Number of subjects: 1206
Study 31082269 — intervention group
Group type: COMPARATOR
Intervention: sb-paclitaxel 80 mg/m2
Number of subjects: 1206
Study 31082269 — intervention group
Group type: EXPERIMENTAL
Intervention: NAB-paclitaxel 125 mg/m2
Number of subjects: 1206
Study 31082269 — intervention group
Group type: EXPERIMENTAL
Intervention: NAB-paclitaxel 150 mg/m2
Number of subjects: 1206
Study 31082269 — intervention group
Group type: EXPERIMENTAL
Intervention: NAB-paclitaxel
Number of subjects: 1206
Study 31082269 — intervention group
Group type: COMPARATOR
Intervention: sb-paclitaxel
Number of subjects: 1206
Study 29252150 — intervention group
Group type: EXPERIMENTAL
Intervention: Whey Protein Supplementation (WPS)
Number of subjects: 47
Study 29252150 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 47
Study 26109117 — intervention group
Group type: EXPERIMENTAL
Intervention: Honevo (90% medical‐grade kanuka honey and 10% glycerine)
Number of subjects: 138
Study 26109117 — intervention group
Group type: COMPARATOR
Intervention: Control cream (Cetomacrogol)
Number of subjects: 138
Study 26109117 — intervention group
Group type: EXPERIMENTAL
Intervention: Honevo
Number of subjects: 138
Study 26109117 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 138
Study 24359432 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention 1 (improvements within the current funding model facilitated through an online chronic disease management network)
Number of subjects: 0
Study 24359432 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention 2 (same components as Intervention 1, plus altered funding to support voluntary patient registration, incentive payments, and a care facilitator)
Number of subjects: 0
Study 24359432 — intervention group
Group type: COMPARATOR
Intervention: Control group (usual care)
Number of subjects: 0
Study 21550957 — intervention group
Group type: EXPERIMENTAL
Intervention: SimpleSTEP (insulin aspart added to the largest meal, titration based on premeal glucose values)
Number of subjects: 296
Study 21550957 — intervention group
Group type: EXPERIMENTAL
Intervention: ExtraSTEP (insulin aspart added to the meal with the largest prandial glucose increment, titration based on postmeal glucose values)
Number of subjects: 296
Study 21550957 — intervention group
Group type: COMPARATOR
Intervention: Both groups (SimpleSTEP and ExtraSTEP)
Number of subjects: 296
Study 17928808 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly iron supplementation (120 mg elemental iron)
Number of subjects: 279
Study 17928808 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly vitamin A supplementation (25,000 IU)
Number of subjects: 279
Study 17928808 — intervention group
Group type: COMPARATOR
Intervention: Iron placebo
Number of subjects: 279
Study 17095339 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone propionate (FP) hydrofluoroalkane 88 mug, twice daily
Number of subjects: 359
Study 17095339 — intervention group
Group type: COMPARATOR
Intervention: Placebo HFA
Number of subjects: 359
Study 15016259 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-submerged technique (group A)
Number of subjects: 84
Study 15016259 — intervention group
Group type: COMPARATOR
Intervention: Submerged technique (group B)
Number of subjects: 84
Study 15016259 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 84
Study 12536544 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilevel positive airway pressure (BiPAP) via facial mask
Number of subjects: 0
Study 12536544 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy alone
Number of subjects: 0
Study 9507512 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-carotene supplementation (30 mg dose)
Number of subjects: 69
Study 9507512 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 69
Study 9507512 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-carotene supplementation
Number of subjects: 69
Study 9507512 — intervention group
Group type: COMPARATOR
Intervention: Beta-carotene supplementation and Placebo
Number of subjects: 69
Study 15552090 — intervention group
Group type: EXPERIMENTAL
Intervention: Uncorrected images
Number of subjects: 63
Study 15552090 — intervention group
Group type: EXPERIMENTAL
Intervention: Corrected images
Number of subjects: 63
Study 15552090 — intervention group
Group type: COMPARATOR
Intervention: Normal controls (repeated study)
Number of subjects: 63
Study 2680497 — intervention group
Group type: EXPERIMENTAL
Intervention: Milrinone
Number of subjects: 230
Study 2680497 — intervention group
Group type: EXPERIMENTAL
Intervention: Digoxin
Number of subjects: 230
Study 2680497 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 230
Study 2680497 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined treatment (Milrinone + Digoxin)
Number of subjects: 230
Study 2680497 — intervention group
Group type: EXPERIMENTAL
Intervention: Milrinone and Digoxin
Number of subjects: 230
Study 2680497 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic treatment (3 months)
Number of subjects: 230
Study 1105178 — intervention group
Group type: EXPERIMENTAL
Intervention: Live, attenuated intranasal influenza A vaccine
Number of subjects: 25
Study 31289983 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomograms for predicting overall survival (OS)
Number of subjects: 6659
Study 31289983 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomograms for predicting cancer-specific survival (CSS)
Number of subjects: 6659
Study 27856633 — intervention group
Group type: EXPERIMENTAL
Intervention: PARI (2 μg/d) with regular sodium diet
Number of subjects: 45
Study 27856633 — intervention group
Group type: EXPERIMENTAL
Intervention: LS + PARI
Number of subjects: 45
Study 27856633 — intervention group
Group type: EXPERIMENTAL
Intervention: LS + PLAC
Number of subjects: 45
Study 27856633 — intervention group
Group type: EXPERIMENTAL
Intervention: LS + PARI (per-protocol analysis)
Number of subjects: 45
Study 27856633 — intervention group
Group type: COMPARATOR
Intervention: RS + PLAC
Number of subjects: 45
Study 25418812 — intervention group
Group type: EXPERIMENTAL
Intervention: KEEP intervention
Number of subjects: 335
Study 22744545 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical treatment using the Cotrel-Dubousset method, assessed preoperatively and 12 months postoperatively.
Number of subjects: 87
Study 22744545 — intervention group
Group type: EXPERIMENTAL
Intervention: SRS-22 HRQL instrument used for quality of life assessment post-surgery.
Number of subjects: 87
Study 20731006 — intervention group
Group type: EXPERIMENTAL
Intervention: Liquid-based cytology (LBC) interpreted by external experts
Number of subjects: 818
Study 20731006 — intervention group
Group type: COMPARATOR
Intervention: Original cytologic interpretation
Number of subjects: 818
Study 18564391 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous whole blood (unmodified)
Number of subjects: 1089